Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$45.59M
↑ 232% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-34.53M
Historical baseline
PeriodValueYoY Change
TTM$45.59M+152.5%
2024$-86.85M-7.1%
2023$-81.07M-154.4%
2022$-31.87M+52.4%
2021$-66.91M-58.5%
2020$-42.22M-36.0%
2019$-31.05M-183.2%
2018$-10.96M-103.6%
2017$-5.38M-